From this view, future investigations should redirect their aims at determining additional mechanisms by which irisin contributes to glucose homeostasis by decreasing hyperlipidemia, fasting glucose, and IR via its action on SCFA-producing bacteria to improve depressive symptoms in AD patients (Figure 4). The gene discussed is FNDC5; the disease is Alzheimer disease.